Skip to main content

Emergency drug know as ATROPINE, is used in treatment of BRADYCARDIA

Drug DescriptionIndicationsDosageSide EffectsDrug InteractionsWarningsPrecautionsOverdosageContraindicationsClinical PharmacologyMedication Guide Side Effects Center ADVERTISEMENT Atropine Table of Contents Drug Description Indications Dosage Side Effects Drug Interactions Warnings Precautions Overdosage Contraindications Clinical Pharmacology Medication Guide Side Effects Center Drug Description ATROPINE SULFATE Injection, USP 0.1 mg/mI (Adult) 0.05 mg/mL (Pediatric) ABBOJECT® Unit of Use Syringe Atropine Sulfate Injection, USP is a sterile, nonpyrogenic isotonic solution of atropine sulfate monohydrate in water for injection with sodium chloride sufficient to render the solution isotonic. It is administered parenterally by subcutaneous, intramuscular or intravenous injection. Each milliliter (mL) contains atropine sulfate, monohydrate 0.1 mg (adult strength) or 0.05 mg (pediatric strength), and sodium chloride, 9 mg. May contain sodium hydroxide and/or sulfuric acid for pH adjustment 0.308 mOsmol/mL (calc.). pH 4.2 (3.0 to 6.5). The solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection. When smaller doses are required the unused portion should be discarded. Atropine Sulfate Injection is a parenteral anticholinergic agent and muscarinic antagonist. Atropine Sulfate, USP is chemically designated 1a H, 5a H-Tropan-3-a ol (±)-tropate(ester), sulfate (2:1) (salt) monohydrate, (C17H23NO3)2 • H2SO4 • H2O, colorless crystals or white crystalline powder very soluble in water. It has the following structural formula: Atrop Atropine, a naturally occurring belladonna alkaloid, is a racemic mixture of equal parts of d- and 1-hyocyamine, whose activity is due almost entirely to the levo isomer of the drug. Sodium Chloride, USP is chemically designated NaCI, a white crystalline powder freely soluble in water. The syringe is molded from a specially formulated polypropylene. Water permeates from inside the container at an extremely slow rate which will have an insignificant effect on solution concentration over the expected shelf life. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the syringe material.

Comments

Post a Comment

Popular posts from this blog

ACLS TACHYCARDIA ALGORITHMS

ACLS Tachycardia Algorithm for Managing Stable Tachycardia Oct 6, 2017 Version control:  This document is current with respect to 2015 American Heart Association Guidelines for CPR and ECC. These guidelines are current until they are replaced on October 2020. If you are reading this page after October 2020, please contact ACLS Training Center at support@acls.net for an updated document. PDF Version  Print PDF Order the full set of printed crash cart cards  Order now  $40 Using the ACLS Tachycardia Algorithm for Managing Stable Tachycardia The key to managing a patient with any tachycardia is to check if pulses are present, decide if the patient is stable or unstable, and then treat the patient based on the patient's condition and rhythm. If the patient does not have a pulse, follow the ACLS Pulseless Arrest Algorithm. If the patient has a pulse, manage the patient using the ACLS Tachycardia Algorithm. Definition of Stable Tachycardia For...
Post a Comment
Read more

Using the Pulseless Arrest Algorithm for Managing PEA

Using the Pulseless Arrest Algorithm for Managing PEA Oct 6, 2017 Version control:  This document is current with respect to 2015 American Heart Association Guidelines for CPR and ECC. These guidelines are current until they are replaced on October 2020. If you are reading this page after October 2020, please contact ACLS Training Center at support@acls.net for an updated document. Patients with PEA have poor outcomes. Their best chance of returning to a perfusing rhythm is through the quick identification of an underlying reversible cause and correct treatment.  As you use the algorithm to manage the PEA patient, remember to consider all the H's and T's, particularly hypovolemia, which is the most common cause of PEA. Also look for drug overdoses or poisonings. Begin with the primary survey to assess the patient's condition: Pulseless Electrical Activity (PEA) occurs when you see a rhythm on the monitor that would normally be associated with a pulse, however the...
Post a Comment
Read more

ABCDE OF RESUSCITATION

The ABCDE approach to resuscitation  The ABCD of resuscitation, plays a vital role in assessing your patient,  this is your initial assessment: A.......Airway and Cervical immobilization  B...... Breathing and Ventilation  C.......Circulation and hemorrhage control  D.......Disability and Neurological deficit E...... Environment and Exposure  First of all make sure that the scene is safe, wear the necessary PPEs Airway When you go to the patient tap for response, "hello can you hear me" if the patient is conscious and vocalising that indicates that the airway is patent, apply cervical collar for a trauma patient with suspected c-spine trauma. Breathing check for breathing, look listen and feel , check for use of accessory muscle and count respiration which is from 12-20c/m, auscultate the chest for lung sound, check Spo2 if need be deliver oxygen. Circulation Look at the colour hands and digit are they blue(cyanosis) or pink, check ...
1 comment
Read more